Guo Y - Search Results

1

WITHDRAWN: Effective suppression of Rituximab-resistant B-cell lymphoma by a comb-like anti-CD20 mAb nanocluster.

Li H, Xu Z, Wu C, Zhao H, Zhang G, Wang H, Ke C, Li B, Guo Y. Li H, et al. Among authors: guo y. Cancer Lett. 2015 Feb 23:S0304-3835(15)00129-9. doi: 10.1016/j.canlet.2015.02.025. Online ahead of print. Cancer Lett. 2015. PMID: 25721087

2

Characterization of a humanized anti-CD20 antibody with potent antitumor activity against B-cell lymphoma.

Wu L, Wang C, Zhang D, Zhang X, Qian W, Zhao L, Wang H, Li B, Guo Y. Wu L, et al. Among authors: guo y. Cancer Lett. 2010 Jun 28;292(2):208-14. doi: 10.1016/j.canlet.2009.12.004. Epub 2010 Jan 6. Cancer Lett. 2010. PMID: 20056316

3

A chimeric SM5-1 antibody inhibits hepatocellular carcinoma cell growth and induces caspase-dependent apoptosis.

Dai J, Jin J, Li B, Wang H, Hou S, Qian W, Kou G, Zhang D, Li J, Tan M, Ma J, Guo Y. Dai J, et al. Among authors: guo y. Cancer Lett. 2007 Dec 18;258(2):208-14. doi: 10.1016/j.canlet.2007.09.002. Epub 2007 Oct 23. Cancer Lett. 2007. PMID: 17959303

4

Construction and characterization of a bispecific anti-CD20 antibody with potent antitumor activity against B-cell lymphoma.

Li B, Zhang X, Shi S, Zhao L, Zhang D, Qian W, Zheng L, Gao J, Wang H, Guo Y. Li B, et al. Among authors: guo y. Cancer Res. 2010 Aug 1;70(15):6293-302. doi: 10.1158/0008-5472.CAN-10-0009. Epub 2010 Jul 14. Cancer Res. 2010. PMID: 20631068

5

A bispecific antibody effectively inhibits tumor growth and metastasis by simultaneous blocking vascular endothelial growth factor A and osteopontin.

Kou G, Shi J, Chen L, Zhang D, Hou S, Zhao L, Fang C, Zheng L, Zhang X, Liang P, Zhang X, Li B, Guo Y. Kou G, et al. Among authors: guo y. Cancer Lett. 2010 Dec 28;299(2):130-6. doi: 10.1016/j.canlet.2010.08.011. Epub 2010 Sep 9. Cancer Lett. 2010. PMID: 20826049

6

Effective suppression of breast tumor growth by an anti-EGFR/ErbB2 bispecific antibody.

Wang S, Chen C, Meng Y, Hu S, Zheng L, Song J, Zhang D, Li B, Guo Y. Wang S, et al. Among authors: guo y. Cancer Lett. 2012 Dec 28;325(2):214-9. doi: 10.1016/j.canlet.2012.07.007. Epub 2012 Jul 10. Cancer Lett. 2012. PMID: 22789781

7

Development of novel tetravalent anti-CD20 antibodies with potent antitumor activity.

Li B, Shi S, Qian W, Zhao L, Zhang D, Hou S, Zheng L, Dai J, Zhao J, Wang H, Guo Y. Li B, et al. Among authors: guo y. Cancer Res. 2008 Apr 1;68(7):2400-8. doi: 10.1158/0008-5472.CAN-07-6663. Cancer Res. 2008. PMID: 18381448

8

Chemotherapy for gastric cancer by finely tailoring anti-Her2 anchored dual targeting immunomicelles.

Li W, Zhao H, Qian W, Li H, Zhang L, Ye Z, Zhang G, Xia M, Li J, Gao J, Li B, Kou G, Dai J, Wang H, Guo Y. Li W, et al. Among authors: guo y. Biomaterials. 2012 Jul;33(21):5349-62. doi: 10.1016/j.biomaterials.2012.04.016. Epub 2012 Apr 28. Biomaterials. 2012. PMID: 22542611

9

Bispecific antibody to ErbB2 overcomes trastuzumab resistance through comprehensive blockade of ErbB2 heterodimerization.

Li B, Meng Y, Zheng L, Zhang X, Tong Q, Tan W, Hu S, Li H, Chen Y, Song J, Zhang G, Zhao L, Zhang D, Hou S, Qian W, Guo Y. Li B, et al. Among authors: guo y. Cancer Res. 2013 Nov 1;73(21):6471-83. doi: 10.1158/0008-5472.CAN-13-0657. Epub 2013 Sep 17. Cancer Res. 2013. PMID: 24046294

10

Nano polymeric carrier fabrication technologies for advanced antitumor therapy.

Li W, Zhao M, Ke C, Zhang G, Zhang L, Li H, Zhang F, Sun Y, Dai J, Wang H, Guo Y. Li W, et al. Among authors: guo y. Biomed Res Int. 2013;2013:305089. doi: 10.1155/2013/305089. Epub 2013 Dec 4. Biomed Res Int. 2013. PMID: 24369011 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

44,680 results

Search Page

Filters